Hardiman O - Search Results

1

Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Mahoney CJ, Ahmed RM, Huynh W, Tu S, Rohrer JD, Bedlack RS, Hardiman O, Kiernan MC. Mahoney CJ, et al. Among authors: hardiman o. CNS Drugs. 2021 May;35(5):483-505. doi: 10.1007/s40263-021-00820-1. Epub 2021 May 15. CNS Drugs. 2021. PMID: 33993457 Review.

2

Amyotrophic lateral sclerosis mimic syndromes: a population-based study.

Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Traynor BJ, et al. Among authors: hardiman o. Arch Neurol. 2000 Jan;57(1):109-13. doi: 10.1001/archneur.57.1.109. Arch Neurol. 2000. PMID: 10634456

3

Symptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis.

Hardiman O. Hardiman O. J Neurol. 2000 Apr;247(4):245-51. doi: 10.1007/s004150050578. J Neurol. 2000. PMID: 10836614 Review.

4

Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.

Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Traynor BJ, et al. Among authors: hardiman om. Arch Neurol. 2000 Aug;57(8):1171-6. doi: 10.1001/archneur.57.8.1171. Arch Neurol. 2000. PMID: 10927797

5

Assessing individual quality of life in amyotrophic lateral sclerosis.

Clarke S, Hickey A, O'Boyle C, Hardiman O. Clarke S, et al. Among authors: hardiman o, o boyle c. Qual Life Res. 2001;10(2):149-58. doi: 10.1023/a:1016704906100. Qual Life Res. 2001. PMID: 11642685

6

An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.

Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Traynor BJ, et al. Among authors: hardiman o. J Neurol. 2003 Apr;250(4):473-9. doi: 10.1007/s00415-003-1026-z. J Neurol. 2003. PMID: 12700914

7

Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Traynor BJ, et al. Among authors: hardiman o. J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1258-61. doi: 10.1136/jnnp.74.9.1258. J Neurol Neurosurg Psychiatry. 2003. PMID: 12933930 Free PMC article.

8

Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis.

Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Morgan RK, et al. Among authors: hardiman o. Am J Respir Crit Care Med. 2005 Feb 1;171(3):269-74. doi: 10.1164/rccm.200403-314OC. Epub 2004 Oct 29. Am J Respir Crit Care Med. 2005. PMID: 15516537

9

Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.

O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, Hardiman O. O'Toole O, et al. Among authors: hardiman o. J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):30-2. doi: 10.1136/jnnp.2007.117788. Epub 2007 Jul 18. J Neurol Neurosurg Psychiatry. 2008. PMID: 17634215

10

Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis.

Hosback S, Hardiman O, Nolan CM, Doyle MA, Gorman G, Lynch C, O'Toole O, Jakeman P. Hosback S, et al. Among authors: o toole o, hardiman o. Growth Horm IGF Res. 2007 Dec;17(6):472-9. doi: 10.1016/j.ghir.2007.06.002. Epub 2007 Aug 13. Growth Horm IGF Res. 2007. PMID: 17697791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters